As of Jan 19
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +1.27% increase from the last price of 3.95.
The current consensus among 5 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.